Nov 9, 2018
“Nature Masterclasses in Scientific Writing and Publishing” provided by Nature Publishing Group will be held in January, sponsored by K-CONNEX. This class will be held for researchers in Neuroscience and related fields, who are especially prospective youths who aim at submission on high-ranked journals. To induce highly interactions among trainers and participants in the class, the number of participants will be kept in only around 25 researchers.
|Date||9:30-17:10, Tuesday 29th January 2019|
|Venue||School & Graduate School of Medicine -Research BuildingB 2nd floor,Kusunoki Campus Kobe University
|Eligibility||Associate and assistant professor class researchers, senior posdoc
※The submission of your abstract is required in advance.
( See the agenda on the back.)
|Number of partcipants||25 persons(first-come-first-served basis)|
|Application/Contact||Send an email with the following matters to E-mail: email@example.com|
|Deadline||28th December, 2018 12:00
Affiliation(University name/Faculty name), Jobtitle, Name,E-mail address, Reason for applying
Angela is Senior Editor for biology at Nature. She holds a BSc and MSc from University of Notre Dame, and a PhD from Northwestern University. Prior to joining Nature, she undertook post-doctoral fellowships at Imperial Cancer Research Fund (Clare Hall Laboratories) and HHMI-Children’s Hospital Boston. Her areas of editorial responsibility include DNA structure and metabolism, RNA structure and metabolism, biophysics of motor proteins, and photosystems.
Fiona joined Nature Communications in March 2016. She was a locum Assistant Editor for Nature Medicine in 2014 and a locum Associate Editor for Nature Reviews Neuroscience in 2015. She obtained her PhD in neuroscience from University College London to study the role of descending facilitation in rodent models of chronic pain. At Mount Sinai School of Medicine, her postdoctoral work investigated molecular mechanisms of chronic pain and addiction. Fiona manages submissions on neurodegeneration and neurological diseases, and is based in the London office.